1. Home
  2. CURR vs AVIR Comparison

CURR vs AVIR Comparison

Compare CURR & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Currenc Group Inc. Ordinary Shares

CURR

Currenc Group Inc. Ordinary Shares

N/A

Current Price

$3.26

Market Cap

395.2M

ML Signal

N/A

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

N/A

Current Price

$5.29

Market Cap

429.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CURR
AVIR
Founded
2013
2012
Country
Singapore
United States
Employees
N/A
N/A
Industry
Business Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
395.2M
429.1M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CURR
AVIR
Price
$3.26
$5.29
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
665.9K
213.1K
Earning Date
05-19-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.00
EPS
N/A
N/A
Revenue
$46,435,412.00
$351,367,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$14.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$2.78
52 Week High
$5.08
$6.45

Technical Indicators

Market Signals
Indicator
CURR
AVIR
Relative Strength Index (RSI) 47.24 47.32
Support Level $2.82 $5.03
Resistance Level $3.62 $5.79
Average True Range (ATR) 0.43 0.21
MACD -0.03 -0.06
Stochastic Oscillator 17.22 14.10

Price Performance

Historical Comparison
CURR
AVIR

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It operates into two reportable segments, which are remittance services and sales of airtime, of which maximum revenue is generated from the Remittance segment. Geographically, the group generates the majority of its geographic revenue from Malaysia.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

Share on Social Networks: